Double Vision Is Common in Parkinson’s, Large Study Finds
Double vision (diplopia) is common in people with Parkinson’s — affecting up to an estimated 30% of patients —…
Articles by Diana Campelo Delgado
Molecular Link Found Between Parkinson’s and Skin Cancer
Researchers have found a molecular link between Parkinson’s disease and melanoma, a type of skin cancer, in the form…
Health Canada Allows Start of DA01 Trial Testing Cell Therapy
BlueRock Therapeutics has received permission from Health Canada to start a Phase 1 clinical trial evaluating DA01, an investigational…
Phase 2 Trial of Cognitive Treatment NYX-458 Resumes
Aptinyx‘s Phase 2 clinical trial evaluating its investigational oral compound NYX-458 for the treatment of cognitive impairment and mild…
Magnetic Nanoparticles May Help Restore Brain Function
Magnetic nanoparticles may help restore brain function by directing nerve cell growth, a new study shows. Researchers believe this technology has…
Protein Fragment in CSF Shows Potential as Diagnostic Biomarker
A protein fragment known as GPR37 is evident in the cerebrospinal fluid of people with Parkinson’s disease, and may be…
Forest Hills Lab Asking to Open Phase 2 Trial of FHL-301 in Parkinson’s
Forest Hills Lab announced plans to soon apply to the U.S. Food and Drug Administration (FDA) for permission to open…
Global PPMI Study Now Enrolling Adults With Parkinson’s Risk Factors
The Parkinson’s Progression Markers Initiative (PPMI), a study sponsored by The Michael J. Fox Foundation, is recruiting people…
COVID-19 Affected Speech, Language Therapies, UK Survey Shows
Lockdown during the COVID-19 pandemic has affected speech and language therapy in patients with Parkinson’s disease, a survey…
Collaboration Tackles Sleep Problems in Parkinson’s
Cambridge Sleep Sciences and Parkinson’s Concierge have entered an agreement to tackle sleep problems in Parkinson’s disease.